The deficiency of miR-214-3p exacerbates cardiac fibrosis via miR-214-3p/NLRC5 axis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The deficiency of miR-214-3p exacerbates cardiac fibrosis via miR-214-3p/NLRC5 axis
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 17, Pages 1845-1856
Publisher
Portland Press Ltd.
Online
2019-08-22
DOI
10.1042/cs20190203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metazoan MicroRNAs
- (2018) David P. Bartel CELL
- NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway
- (2017) Hongtao Zhou et al. Molecular Medicine Reports
- MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis
- (2016) Hua Dong et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Glutamine protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions through inhibition of the transforming growth factor-β1-Smad3 pathway
- (2016) Hong Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway
- (2016) Hai-Li Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis
- (2016) Tao Xu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts
- (2016) Wen-Si Zhu et al. Oncotarget
- MiR-125b is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
- (2015) Varun Nagpal et al. CIRCULATION
- lncRNA-MIAT Regulates Microvascular Dysfunction by Functioning as a Competing Endogenous RNANovelty and Significance
- (2015) Biao Yan et al. CIRCULATION RESEARCH
- MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis
- (2015) Quanlu Duan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts
- (2015) Min Sun et al. Scientific Reports
- The microRNA-15 family inhibits the TGFβ-pathway in the heart
- (2014) Anke J. Tijsen et al. CARDIOVASCULAR RESEARCH
- Mesenchymal–endothelial transition contributes to cardiac neovascularization
- (2014) Eric Ubil et al. NATURE
- The pathogenesis of cardiac fibrosis
- (2013) Ping Kong et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Extracellular Matrix Secretion by Cardiac Fibroblasts
- (2013) Mélanie Abonnenc et al. CIRCULATION RESEARCH
- The Structure of Human Argonaute-2 in Complex with miR-20a
- (2012) Elad Elkayam et al. CELL
- Transcriptional targeting by microRNA-Polycomb complexes: A novel route in cell fate determination
- (2012) Giuseppe Zardo et al. CELL CYCLE
- Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
- (2012) Xiaoying Zhang et al. CIRCULATION RESEARCH
- MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death
- (2012) Arin B. Aurora et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNAs, transforming growth factor beta-1, and tissue fibrosis
- (2012) Timothy Bowen et al. JOURNAL OF PATHOLOGY
- Myofibroblast-mediated mechanisms of pathological remodelling of the heart
- (2012) Karl T. Weber et al. Nature Reviews Cardiology
- Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway
- (2010) Han Xiao et al. CARDIOVASCULAR RESEARCH
- Origins of Cardiac Fibroblasts
- (2010) Elisabeth M. Zeisberg et al. CIRCULATION RESEARCH
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More